372 related articles for article (PubMed ID: 32976922)
1. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
Li T; Zheng R; Xu L; Zhou M; Wang X; Guo Q; Ji H; Li L
Toxicol Appl Pharmacol; 2020 Dec; 408():115248. PubMed ID: 32976922
[TBL] [Abstract][Full Text] [Related]
2. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
3. Alpha-naphthylisothiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes.
Li X; Liu R; Yu L; Yuan Z; Sun R; Yang H; Zhang L; Jiang Z
Toxicology; 2016 Aug; 370():106-115. PubMed ID: 27702592
[TBL] [Abstract][Full Text] [Related]
4. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
[TBL] [Abstract][Full Text] [Related]
5. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
[TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis.
Liu J; Liu J; Meng C; Huang C; Liu F; Xia C
Phytomedicine; 2022 Jul; 102():154173. PubMed ID: 35605478
[TBL] [Abstract][Full Text] [Related]
7. Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats.
Wang L; Wu G; Wu F; Jiang N; Lin Y
J Ethnopharmacol; 2017 Jan; 196():178-185. PubMed ID: 27988401
[TBL] [Abstract][Full Text] [Related]
8. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical Effects of Emodin on ANIT-Induced Intrahepatic Cholestasis and Herb-Induced Hepatotoxicity in Mice.
Wang X; Han L; Bi Y; Li C; Gao X; Fan G; Zhang Y
Toxicol Sci; 2019 Mar; 168(1):264-278. PubMed ID: 30517764
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats.
Wang M; Liu F; Yao Y; Zhang Q; Lu Z; Zhang R; Liu C; Lin C; Zhu C
J Ethnopharmacol; 2021 Apr; 270():113816. PubMed ID: 33444723
[TBL] [Abstract][Full Text] [Related]
11. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.
Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ
Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837
[TBL] [Abstract][Full Text] [Related]
12. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.
Cui YJ; Aleksunes LM; Tanaka Y; Goedken MJ; Klaassen CD
Toxicol Sci; 2009 Jul; 110(1):47-60. PubMed ID: 19407337
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
[TBL] [Abstract][Full Text] [Related]
14. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
15. Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism.
Meng F; Zong W; Wei X; Tao Y; Wang G; Liao Z; Chen M
Phytomedicine; 2021 Jul; 87():153588. PubMed ID: 34091148
[TBL] [Abstract][Full Text] [Related]
16. 7, 8-Dihydroxy-4-methyl coumarin alleviates cholestasis via activation of the Farnesoid X receptor in vitro and in vivo.
Refat M; Zhang G; Ahmed A Saad A; Baldi S; Zheng F; Wu X
Chem Biol Interact; 2023 Jan; 370():110331. PubMed ID: 36581201
[TBL] [Abstract][Full Text] [Related]
17. 18β-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1/FXR signaling pathway.
Wu SY; Cui SC; Wang L; Zhang YT; Yan XX; Lu HL; Xing GZ; Ren J; Gong LK
Acta Pharmacol Sin; 2018 Dec; 39(12):1865-1873. PubMed ID: 30061734
[TBL] [Abstract][Full Text] [Related]
18. The choleretic role of tauroursodeoxycholic acid exacerbates alpha-naphthylisothiocyanate induced cholestatic liver injury through the FXR/BSEP pathway.
Zhao J; Song G; Weng F; Li Y; Zou B; Jin J; Yan D; Sun X; Liu C; Qiu FR
J Appl Toxicol; 2023 Jul; 43(7):1095-1103. PubMed ID: 36787806
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of n-Butanol extract and iridoid glycosides of Veronica ciliata Fisch. Against ANIT-induced cholestatic liver injury in mice.
Hua W; Zhang S; Lu Q; Sun Y; Tan S; Chen F; Tang L
J Ethnopharmacol; 2021 Feb; 266():113432. PubMed ID: 33011367
[TBL] [Abstract][Full Text] [Related]
20. Exploration of Hepatoprotective Effect of Gentiopicroside on Alpha-Naphthylisothiocyanate-Induced Cholestatic Liver Injury in Rats by Comprehensive Proteomic and Metabolomic Signatures.
Han H; Xu L; Xiong K; Zhang T; Wang Z
Cell Physiol Biochem; 2018; 49(4):1304-1319. PubMed ID: 30223280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
